Does the media prefer AGL or IDHC?

In the previous week, ANGLE and ANGLE both had 1 articles in the media. Integrated Diagnostics' average media sentiment score of 1.17 beat ANGLE's score of -0.32 indicating that Integrated Diagnostics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ANGLE 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Integrated Diagnostics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to IDHC or PRM?

In the previous week, Proteome Sciences had 2 more articles in the media than Integrated Diagnostics. MarketBeat recorded 3 mentions for Proteome Sciences and 1 mentions for Integrated Diagnostics. Integrated Diagnostics' average media sentiment score of 1.17 beat Proteome Sciences' score of 0.97 indicating that Integrated Diagnostics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integrated Diagnostics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Proteome Sciences 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to IDHC or VRCI?

In the previous week, Verici Dx had 1 more articles in the media than Integrated Diagnostics. MarketBeat recorded 2 mentions for Verici Dx and 1 mentions for Integrated Diagnostics. Integrated Diagnostics' average media sentiment score of 1.17 beat Verici Dx's score of -1.59 indicating that Integrated Diagnostics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integrated Diagnostics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Verici Dx 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Very Negative

Integrated Diagnostics (IDHC) Competitors

GBX 0.49 -0.01 (-1.01%)

As of 04:33 AM Eastern

Compare

IDHC vs. AGL, GENI, PRM, VRCI, and DMTR

Should you buy Integrated Diagnostics stock or one of its competitors? MarketBeat compares Integrated Diagnostics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Integrated Diagnostics include ANGLE (AGL), GENinCode (GENI), Proteome Sciences (PRM), Verici Dx (VRCI), and Deepmatter Group (DMTR). These companies are all part of the "diagnostics & research" industry.

How does Integrated Diagnostics compare to ANGLE?

ANGLE (LON:AGL) and Integrated Diagnostics (LON:IDHC) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, institutional ownership, analyst recommendations, profitability and media sentiment.

In the previous week, ANGLE and ANGLE both had 1 articles in the media. Integrated Diagnostics' average media sentiment score of 1.17 beat ANGLE's score of -0.32 indicating that Integrated Diagnostics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ANGLE	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Integrated Diagnostics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Integrated Diagnostics has a net margin of 17.46% compared to ANGLE's net margin of -732.40%. Integrated Diagnostics' return on equity of 42.26% beat ANGLE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ANGLE	-732.40%	-89.82%	-29.89%
Integrated Diagnostics	17.46%	42.26%	9.69%

Integrated Diagnostics has higher revenue and earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than Integrated Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ANGLE	£2.62M	2.89	-£21.76M	-£4.80	N/A
Integrated Diagnostics	£8.35B	0.00	£4.01T	£250.03	0.00

ANGLE has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market. Comparatively, Integrated Diagnostics has a beta of 0.376, meaning that its share price is 62% less volatile than the broader market.

17.5% of ANGLE shares are held by institutional investors. Comparatively, 7.7% of Integrated Diagnostics shares are held by institutional investors. 2.7% of ANGLE shares are held by insiders. Comparatively, 49.7% of Integrated Diagnostics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Integrated Diagnostics beats ANGLE on 10 of the 12 factors compared between the two stocks.

How does Integrated Diagnostics compare to GENinCode?

GENinCode (LON:GENI) and Integrated Diagnostics (LON:IDHC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings, dividends and media sentiment.

4.5% of GENinCode shares are held by institutional investors. Comparatively, 7.7% of Integrated Diagnostics shares are held by institutional investors. 8.7% of GENinCode shares are held by insiders. Comparatively, 49.7% of Integrated Diagnostics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Integrated Diagnostics has higher revenue and earnings than GENinCode. GENinCode is trading at a lower price-to-earnings ratio than Integrated Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GENinCode	£2.91M	2.43	-£6.10M	-£2.35	N/A
Integrated Diagnostics	£8.35B	0.00	£4.01T	£250.03	0.00

In the previous week, Integrated Diagnostics had 1 more articles in the media than GENinCode. MarketBeat recorded 1 mentions for Integrated Diagnostics and 0 mentions for GENinCode. Integrated Diagnostics' average media sentiment score of 1.17 beat GENinCode's score of 0.00 indicating that Integrated Diagnostics is being referred to more favorably in the news media.

Company	Overall Sentiment
GENinCode	Neutral
Integrated Diagnostics	Positive

Integrated Diagnostics has a net margin of 17.46% compared to GENinCode's net margin of -185.47%. Integrated Diagnostics' return on equity of 42.26% beat GENinCode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GENinCode	-185.47%	-409.40%	-63.99%
Integrated Diagnostics	17.46%	42.26%	9.69%

GENinCode has a beta of 0.588, meaning that its stock price is 41% less volatile than the broader market. Comparatively, Integrated Diagnostics has a beta of 0.376, meaning that its stock price is 62% less volatile than the broader market.

Summary

Integrated Diagnostics beats GENinCode on 11 of the 13 factors compared between the two stocks.

How does Integrated Diagnostics compare to Proteome Sciences?

Integrated Diagnostics (LON:IDHC) and Proteome Sciences (LON:PRM) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

In the previous week, Proteome Sciences had 2 more articles in the media than Integrated Diagnostics. MarketBeat recorded 3 mentions for Proteome Sciences and 1 mentions for Integrated Diagnostics. Integrated Diagnostics' average media sentiment score of 1.17 beat Proteome Sciences' score of 0.97 indicating that Integrated Diagnostics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integrated Diagnostics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Proteome Sciences	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Integrated Diagnostics has a net margin of 17.46% compared to Proteome Sciences' net margin of -81.50%. Integrated Diagnostics' return on equity of 42.26% beat Proteome Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integrated Diagnostics	17.46%	42.26%	9.69%
Proteome Sciences	-81.50%	33.80%	-19.25%

Integrated Diagnostics has higher revenue and earnings than Proteome Sciences. Proteome Sciences is trading at a lower price-to-earnings ratio than Integrated Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integrated Diagnostics	£8.35B	0.00	£4.01T	£250.03	0.00
Proteome Sciences	£3.76M	1.87	-£4.08M	-£1.04	N/A

Integrated Diagnostics has a beta of 0.376, suggesting that its stock price is 62% less volatile than the broader market. Comparatively, Proteome Sciences has a beta of 0.173, suggesting that its stock price is 83% less volatile than the broader market.

7.7% of Integrated Diagnostics shares are held by institutional investors. Comparatively, 0.0% of Proteome Sciences shares are held by institutional investors. 49.7% of Integrated Diagnostics shares are held by company insiders. Comparatively, 36.7% of Proteome Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Integrated Diagnostics beats Proteome Sciences on 11 of the 13 factors compared between the two stocks.

How does Integrated Diagnostics compare to Verici Dx?

Integrated Diagnostics (LON:IDHC) and Verici Dx (LON:VRCI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations and institutional ownership.

In the previous week, Verici Dx had 1 more articles in the media than Integrated Diagnostics. MarketBeat recorded 2 mentions for Verici Dx and 1 mentions for Integrated Diagnostics. Integrated Diagnostics' average media sentiment score of 1.17 beat Verici Dx's score of -1.59 indicating that Integrated Diagnostics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integrated Diagnostics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Verici Dx	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Very Negative

7.7% of Integrated Diagnostics shares are owned by institutional investors. Comparatively, 15.7% of Verici Dx shares are owned by institutional investors. 49.7% of Integrated Diagnostics shares are owned by insiders. Comparatively, 1.2% of Verici Dx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Integrated Diagnostics has a net margin of 17.46% compared to Verici Dx's net margin of -468.31%. Integrated Diagnostics' return on equity of 42.26% beat Verici Dx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integrated Diagnostics	17.46%	42.26%	9.69%
Verici Dx	-468.31%	-178.37%	-26.14%

Integrated Diagnostics has higher revenue and earnings than Verici Dx. Verici Dx is trading at a lower price-to-earnings ratio than Integrated Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integrated Diagnostics	£8.35B	0.00	£4.01T	£250.03	0.00
Verici Dx	£1.91M	3.12	-£6.56M	-£2.90	N/A

Integrated Diagnostics has a beta of 0.376, indicating that its stock price is 62% less volatile than the broader market. Comparatively, Verici Dx has a beta of 1.258, indicating that its stock price is 26% more volatile than the broader market.

Summary

Integrated Diagnostics beats Verici Dx on 9 of the 13 factors compared between the two stocks.

How does Integrated Diagnostics compare to Deepmatter Group?

Integrated Diagnostics (LON:IDHC) and Deepmatter Group (LON:DMTR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership, media sentiment and risk.

In the previous week, Integrated Diagnostics had 1 more articles in the media than Deepmatter Group. MarketBeat recorded 1 mentions for Integrated Diagnostics and 0 mentions for Deepmatter Group. Integrated Diagnostics' average media sentiment score of 1.17 beat Deepmatter Group's score of 0.00 indicating that Integrated Diagnostics is being referred to more favorably in the media.

Company	Overall Sentiment
Integrated Diagnostics	Positive
Deepmatter Group	Neutral

Integrated Diagnostics has higher revenue and earnings than Deepmatter Group. Deepmatter Group is trading at a lower price-to-earnings ratio than Integrated Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integrated Diagnostics	£8.35B	0.00	£4.01T	£250.03	0.00
Deepmatter Group	£1.04M	0.00	N/A	-£0.30	N/A

Integrated Diagnostics has a net margin of 17.46% compared to Deepmatter Group's net margin of 0.00%. Integrated Diagnostics' return on equity of 42.26% beat Deepmatter Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integrated Diagnostics	17.46%	42.26%	9.69%
Deepmatter Group	N/A	N/A	N/A

7.7% of Integrated Diagnostics shares are held by institutional investors. 49.7% of Integrated Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Integrated Diagnostics beats Deepmatter Group on 10 of the 10 factors compared between the two stocks.

Get Integrated Diagnostics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IDHC vs. The Competition

Export

Metric	Integrated Diagnostics	Diagnostics & Research Industry	Medical Sector	LON Exchange
Market Cap	£2.85M	£558.63M	£6.44B	£2.79B
Dividend Yield	1.50%	3.35%	2.69%	6.16%
P/E Ratio	0.00	78.86	24.67	366.40
Price / Sales	0.00	637.77	528.41	86,135.43
Price / Cash	N/A	11.42	44.82	27.85
Price / Book	0.00	3.37	10.76	7.87
Net Income	£4.01T	£334.07B	£3.56B	£5.89B
7 Day Performance	-15.22%	1.19%	1.03%	-0.79%
1 Month Performance	-16.38%	-2.34%	0.45%	-0.60%
1 Year Performance	40.80%	5.05%	29.69%	69.52%

Integrated Diagnostics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IDHC Integrated Diagnostics	N/A	GBX 0.49 -1.0%	N/A	+41.3%	£2.85M	£8.35B	0.00	6,692	News Coverage
AGL ANGLE	N/A	GBX 2.35 -11.3%	N/A	-67.6%	£7.58M	£2.62M	N/A	650	News Coverage Gap Up
GENI GENinCode	N/A	GBX 0.90 -5.3%	N/A	-58.3%	£6.53M	£2.91M	N/A	2,300	Gap Up
PRM Proteome Sciences	N/A	GBX 1.60 flat	N/A	-44.2%	£5.61M	£3.76M	N/A	240
VRCI Verici Dx	N/A	GBX 0.35 -6.7%	N/A	-70.5%	£5.30M	£1.91M	N/A	19	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:IDHC) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Integrated Diagnostics (IDHC) Competitors

IDHC vs. AGL, GENI, PRM, VRCI, and DMTR

How does Integrated Diagnostics compare to ANGLE?

Summary

How does Integrated Diagnostics compare to GENinCode?

Summary

How does Integrated Diagnostics compare to Proteome Sciences?

Summary

How does Integrated Diagnostics compare to Verici Dx?

Summary

How does Integrated Diagnostics compare to Deepmatter Group?

Summary

Media Sentiment Over Time

IDHC vs. The Competition

Integrated Diagnostics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Integrated Diagnostics (IDHC) Competitors

IDHC vs. AGL, GENI, PRM, VRCI, and DMTR

How does Integrated Diagnostics compare to ANGLE?

Does the media prefer AGL or IDHC?

Is AGL or IDHC more profitable?

Which has stronger earnings & valuation, AGL or IDHC?

Which has more volatility and risk, AGL or IDHC?

Do institutionals and insiders hold more shares of AGL or IDHC?

Summary

How does Integrated Diagnostics compare to GENinCode?

Do institutionals and insiders believe in GENI or IDHC?

Which has stronger earnings and valuation, GENI or IDHC?

Does the media prefer GENI or IDHC?

Is GENI or IDHC more profitable?

Which has more risk and volatility, GENI or IDHC?

Summary

How does Integrated Diagnostics compare to Proteome Sciences?

Does the media refer more to IDHC or PRM?

Is IDHC or PRM more profitable?

Which has higher valuation and earnings, IDHC or PRM?

Which has more volatility and risk, IDHC or PRM?

Do institutionals and insiders believe in IDHC or PRM?

Summary

How does Integrated Diagnostics compare to Verici Dx?

Does the media refer more to IDHC or VRCI?

Do insiders and institutionals believe in IDHC or VRCI?

Is IDHC or VRCI more profitable?

Which has preferable earnings & valuation, IDHC or VRCI?

Which has more risk and volatility, IDHC or VRCI?

Summary

How does Integrated Diagnostics compare to Deepmatter Group?

Does the media refer more to IDHC or DMTR?

Which has better earnings & valuation, IDHC or DMTR?

Is IDHC or DMTR more profitable?

Do institutionals and insiders hold more shares of IDHC or DMTR?

Summary

Media Sentiment Over Time

IDHC vs. The Competition

Integrated Diagnostics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools